Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. CTEV
CTEV logo

CTEV Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Claritev Corp (CTEV) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
17.600
1 Day change
4.20%
52 Week Range
74.070
Analysis Updated At
2026/03/13
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Claritev Corp (CTEV) is not a strong buy at the moment for a beginner investor with a long-term focus. The stock shows bearish technical indicators, weak financial performance, and lacks strong positive catalysts. While hedge funds are increasing their positions, the company's declining profitability and mixed analyst ratings suggest caution. It is better to hold off on investing until clearer positive trends emerge.

Technical Analysis

The stock exhibits bearish technical indicators. The MACD is above 0 but positively contracting, suggesting weakening momentum. RSI is neutral at 38.125, not signaling oversold or overbought conditions. Moving averages are bearish (SMA_200 > SMA_20 > SMA_5), indicating a downward trend. The stock is trading near its pivot level of 15.833, with key support at 13.497 and resistance at 18.169.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
8
Buy
3

Positive Catalysts

  • Hedge funds are significantly increasing their positions, with a 573.17% rise in buying activity over the last quarter. Analysts from Citi and Guggenheim maintain a 'Buy' rating, albeit with reduced price targets.

Neutral/Negative Catalysts

  • The stock price has dropped significantly in the regular and post-market sessions (-4.53% and -2.00%, respectively). Financial performance in Q4 2025 shows declining net income (-41.60% YoY), EPS (-42.91% YoY), and gross margin (-7.99% YoY). Analyst price targets have been lowered across the board, and the company's guidance for 2026 appears conservative. No recent news or congress trading data is available to provide additional positive sentiment.

Financial Performance

In Q4 2025, revenue increased by 6.21% YoY to $246.55M. However, net income dropped by 41.60% YoY to -$80.57M, and EPS fell by 42.91% YoY to -4.87. Gross margin also declined to 26.25%, down 7.99% YoY, indicating worsening profitability.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts have lowered price targets significantly. Citi reduced the target from $63 to $21, Guggenheim from $43 to $38, and Wells Fargo from $33 to $30. While Citi and Guggenheim maintain 'Buy' ratings, Wells Fargo has an 'Equal Weight' rating, reflecting mixed sentiment. Analysts cite conservative guidance and incremental investments as reasons for the lowered targets.

Wall Street analysts forecast CTEV stock price to rise
3 Analyst Rating
Wall Street analysts forecast CTEV stock price to rise
2 Buy
1 Hold
0 Sell
Moderate Buy
Current: 16.890
sliders
Low
33
Averages
62
High
90
Current: 16.890
sliders
Low
33
Averages
62
High
90
Citi
Daniel Grosslight
Buy
downgrade
$63 -> $21
AI Analysis
2026-02-25
Reason
Citi
Daniel Grosslight
Price Target
$63 -> $21
AI Analysis
2026-02-25
downgrade
Buy
Reason
Citi analyst Daniel Grosslight lowered the firm's price target on Claritev to $21 from $63 and keeps a Buy rating on the shares.
Guggenheim
Buy
maintain
$43 -> $38
2026-02-24
Reason
Guggenheim
Price Target
$43 -> $38
2026-02-24
maintain
Buy
Reason
Guggenheim lowered the firm's price target on Claritev to $38 from $43 and keeps a Buy rating on the shares. Claritev reported "solid" Q4 results and while 2026 revenue and EBITDA guidance "optically fell slightly short of expectations," these can be explained away by conservatism on underlying topline drivers of the business and incremental investments via M&A flow-through and building out its international infrastructure, the analyst tells investors.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CTEV
Unlock Now

People Also Watch